Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterization of Cav1.4 in Psoriasis
NCT04459780Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Oct 2016
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Expression of Cav1.4 calcium channels in Th17 lymphocytes. Started Oct 2016; status: completed.
Beyond the preview
Go deeper on NCT04459780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04459780.